Zoetis Inc. (ZTS) News
Filter ZTS News Items
ZTS News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
ZTS News Highlights
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
Latest ZTS News From Around the Web
Below are the latest news stories about ZOETIS INC that investors may wish to consider to help them evaluate ZTS as an investment opportunity.
Investors in Zoetis (NYSE:ZTS) have unfortunately lost 18% over the last three yearsFor many investors, the main point of stock picking is to generate higher returns than the overall market. But the risk... |
How to Boost Your Portfolio with Top Medical Stocks Set to Beat EarningsWhy investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates. |
Zoetis (ZTS) Surpasses Market Returns: Some Facts Worth KnowingZoetis (ZTS) closed at $165.02 in the latest trading session, marking a +0.94% move from the prior day. |
Is Zoetis Inc. (NYSE: ZTS) Overvalued? Or Is It Worth Buying Now?Zoetis's recent report has investors wondering if the company's stock is overvalued. Or is it in the buy range? As such, the Editorial Advisory and Securities Review Committee of BetterInvesting Magazine considers Zoetis (NYSE: ZTS) as worthy of further study and has named Zoetis its "Stock to Study" for the March 2025 issue for investors' informational and educational use. |
Zoetis to Host Webcast and Conference Call on Fourth Quarter and Full Year 2024 Financial ResultsPARSIPPANY, N.J., January 07, 2025--Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, February 13, 2025. Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer Wetteny Joseph will review fourth quarter and full year 2024 financial results and respond to questions from financial analysts during the call. |
SDZNY vs. ZTS: Which Stock Is the Better Value Option?SDZNY vs. ZTS: Which Stock Is the Better Value Option? |
An Intrinsic Calculation For Zoetis Inc. (NYSE:ZTS) Suggests It's 34% UndervaluedKey Insights Zoetis' estimated fair value is US$248 based on 2 Stage Free Cash Flow to Equity Current share price of... |
Is Zoetis Inc. (ZTS) the Best Pharma Dividend Stock to Buy In 2024?We recently compiled a list of the 13 Best Pharma Dividend Stocks To Buy In 2024. In this article, we are going to take a look at where Zoetis Inc. (NYSE:ZTS) stands against the other pharma dividend stocks. The pharmaceutical industry in 2024 faced a relatively quiet year, with deal volumes similar to 2023 but lower […] |
Zoetis (ZTS) is a Top-Ranked Growth Stock: Should You Buy?The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage. |
Zoetis Inc. (ZTS): A Bull Case TheoryWe came across a bullish thesis on Zoetis Inc. (NYSE:ZTS) on Substack by Best Anchor Stocks. In this article, we will summarize the bulls’ thesis on ZTS. Zoetis Inc. (NYSE:ZTS)’s share was trading at $164.70 as of Dec 24th. ZTS’s trailing and forward P/E were 30.96 and 28.41 respectively according to Yahoo Finance. Zoetis delivered an impressive […] |